Evaluation of the inflammation-based modified Glasgow Prognostic Score (mGPS) as a prognostic and predictive biomarker in patients with metastatic colorectal cancer receiving first-line chemotherapy: a post hoc analysis of the randomized phase III XELAVIRI trial (AIO KRK0110)

Autor: Boukovala, M., Modest, D.P., Ricard, I., Fischer von Weikersthal, L., Decker, T., Vehling-Kaiser, U., Uhlig, J., Schenk, M., Freiberg-Richter, J., Peuser, B., Denzlinger, C., Peveling Genannt Reddemann, C., Graeven, U., Schuch, G., Schwaner, I., Heinrich, K., Neumann, J., Jung, A., Held, S., Stintzing, S., Heinemann, V., Michl, M.

Publikováno v: In ESMO Open May 2024 9(5)

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer—central evaluation of FIRE-3

Autor: Modest, D.P., Denecke, T., Pratschke, J., Ricard, I., Lang, H., Bemelmans, M., Becker, T., Rentsch, M., Seehofer, D., Bruns, C.J., Gebauer, B., Modest, H.I., Held, S., Folprecht, G., Heinemann, V., Neumann, U.P.

Publikováno v: In European Journal of Cancer January 2018 88:77-86

Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group

Autor: Modest, D.P. ^*, Ricard, I., Heinemann, V., Hegewisch-Becker, S., Schmiegel, W., Porschen, R., Stintzing, S., Graeven, U., Arnold, D., von Weikersthal, L.F., Giessen-Jung, C., Stahler, A., Schmoll, H.J., Jung, A., Kirchner, T., Tannapfel, A., Reinacher-Schick, A.

Publikováno v: In Annals of Oncology September 2016 27(9):1746-1753

Methylated free-circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancer

Autor: Herbst, A, Vdovin, N, Gacesa, S, Philipp, A, Nagel, D, Holdt, LM, Op den Winkel, M, Heinemann, V, Stieber, P, Graeven, U, Reinacher-Schick, A, Arnold, D, Ricard, I, Mansmann, U, Hegewisch-Becker, S, Kolligs, F T

Publikováno v: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP

Detection of methylated free-circulating DNA (mfcDNA) for hyperplastic polyposis 1 (HPP1) in blood is correlated with a poor prognosis for patients with metastatic colorectal cancers (mCRC). Here, we analyzed the plasma levels of HPP1 mfcDNA in mCRC

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::9ef170551d5c488d1933774e358265e7
https://hdl.handle.net/10400.26/19005